NRX Pharmaceuticals, Inc. (NRXP) stock
NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.80+0.35 (+14.29%)
Close on Nov 18, 2026Market cap $121.23MP/E –Yield –
NRX Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
NRX Pharmaceuticals's pe ratio was 813.6× on Jan 31, 2020.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Jan 31, 2020 | 813.6× | +6.9 |
| 2019 | Dec 31, 2019 | 806.8× | – |
See a number that looks wrong?